ARS-CoV-2 (COVID-19) in patients with some degree of mmunosuppression

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

  2020cited by this paper
• Should cyclosporine be useful in renal transplant recipients affected by SARS-CoV-2?

  2020cited by this paper
• [EMCAM (Multiple Sclerosis Autonomous Community of Madrid) document for the management of patients with multiple sclerosis during the SARS-CoV-2 pandemic].

  2020cited by this paper
• Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report

  2020cited by this paper
• A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir

  2020cited by this paper
• COVID‐19 in recent heart transplant recipients: Clinicopathologic features and early outcomes

  2020cited by this paper
• When a global pandemic complicates cancer care

  2020cited by this paper
• Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis.

  2020cited by this paper
• Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy

  2020cited by this paper
• Decision-making on management of ms and nmosd patients during the COVID-19 pandemic: A latin american survey

  2020cited by this paper
• Attenuated early inflammatory response in solid organ recipients with COVID‐19

  2020cited by this paper
• A Novel Coronavirus from Patients with Pneumonia in China, 2019

  2020cited by this paper
• Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

  2020cited by this paper
• Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study

  2020cited by this paper
• Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus

  2020cited by this paper
• Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

  2020cited by this paper
• Consistent Detection of 2019 Novel Coronavirus in Saliva

  2020cited by this paper
• Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

  2020cited by this paper
• Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes

  2020cited by this paper
• Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

  2020cited by this paper
• Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China

  2020cited by this paper
• Clinical Characteristics of Coronavirus Disease 2019 in China

  2020cited by this paper
• Risk of COVID-19 for patients with cancer

  2020cited by this paper
• Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks

  2020cited by this paper
• Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

  2020cited by this paper
• Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China

  2020cited by this paper
• Co‐infection of SARS‐CoV‐2 and HIV in a patient in Wuhan city, China

  2020cited by this paper
• A Review of Coronavirus Disease-2019 (COVID-19)

  2020cited by this paper
• The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status

  2020cited by this paper
• A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

  2020cited by this paper
• Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?

  2020cited by this paper
• Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic

  2020cited by this paper
• SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China

  2020cited by this paper
• Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

  2020cited by this paper
• Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.

  2020cited by this paper
• Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

  2020cited by this paper
• Perioperative Presentation of COVID‐19 Disease in a Liver Transplant Recipient

  2020cited by this paper
• Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

  2020cited by this paper
• COVID-19 in kidney transplant recipients

  2020cited by this paper
• Diabetes is a risk factor for the progression and prognosis of COVID‐19

  2020cited by this paper
• Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective

  2020cited by this paper
• Kidney disease is associated with in-hospital death of patients with COVID-19

  2020cited by this paper
• The COVID-19 pandemic and the use of MS disease-modifying therapies

  2020cited by this paper
• Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies

  2020cited by this paper
• COVID 19 and the Patient with Obesity – The Editors Speak Out

  2020cited by this paper
• Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic

  2020cited by this paper
• Maintaining HIV care during the COVID-19 pandemic

  2020cited by this paper
• Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study

  2020cited by this paper
• In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends

  2020cited by this paper
• COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis.

  2020cited by this paper
• Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis

  2020cited by this paper
• Compassionate Use of Remdesivir for Patients with Severe Covid-19

  2020cited by this paper
• Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.

  2020cited by this paper
• COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?

  2020cited by this paper
• Cancer Center Recommendations to Mitigate COVID-19 Impact in Patients With Cancer: Low-Resource Settings Version

  2020cited by this paper
• Could HIV infection alter the clinical course of SARS‐CoV‐2 infection? When less is better

  2020cited by this paper
• The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysis

  2020cited by this paper
• Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions

  2020cited by this paper
• Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome

  2020cited by this paper
• Crucial Aspects of the Management of Solid Organ Transplant Patient with COVID-19: A Narrative Review

  2020cited by this paper
• Severe COVID-19 in a renal transplant recipient: A focus on pharmacokinetics

  2020cited by this paper
• Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19

  2020cited by this paper
• RECOVERY trial: the UK covid-19 study resetting expectations for clinical trials

  2020cited by this paper
• Strategies for prevention and control of the 2019 novel coronavirus disease in the department of kidney transplantation

  2020cited by this paper
• Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

  2020cited by this paper
• Convalescent plasma in Covid-19: Possible mechanisms of action

  2020cited by this paper
• Myasthenic crisis in COVID-19

  2020cited by this paper
• Dermatological diseases presented before COVID‐19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID‐19?

  2020cited by this paper
• COVID‐19 in patients with myasthenia gravis

  2020cited by this paper
• RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

  2020cited by this paper
• Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

  2020cited by this paper
• Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders

  2020cited by this paper
• COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome

  2020cited by this paper
• A lysosome-targetable near infrared fluorescent probe for glutathione sensing and live-cell imaging

  2019cited by this paper
• Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission

  2018cited by this paper
• Infection-related health care utilization among people with and without multiple sclerosis

  2017cited by this paper
• Biomarkers of immunosuppression

  2016cited by this paper
• Disease-modifying therapies and infectious risks in multiple sclerosis

  2016cited by this paper
• Immunosuppression for the non-transplant physician: what should you know?

  2013cited by this paper
• Coronavirus Diversity, Phylogeny and Interspecies Jumping

  2009cited by this paper
• Severe Acute Respiratory Syndrome in Children

  2007cited by this paper
• SARS: Systematic Review of Treatment Effects

  2006cited by this paper
• Inmunología celular y molecular

  1995cited by this paper

• Association of COVID-19 with Comorbidities: An Update

  2023cites this paper
• The comparison of clinical, laboratory, and radiological findings in immunocompromised and immunocompetent patients with COVID‐19: A case‐control study

  2023cites this paper
• SARS-CoV-2 and HIV: Impact on Pulmonary Epithelial Cells

  2022cites this paper
• Resiliencia en tiempos de pandemia por COVID-19 en estudiantes de la Universidad Nacional de Loja

  2022cites this paper
• Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals

  2022cites this paper
• Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19

  2021cites this paper
• Subphenotyping of Mexican Patients With COVID-19 at Preadmission To Anticipate Severity Stratification: Age-Sex Unbiased Meta-Clustering Technique

  2021cites this paper